• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (70)
    • Electroconvulsive therapy (ECT) in Parkinson's disease: ECS and dopamine enhancement.
    • Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
    • Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.
    • Research for North Carolina: The University Cancer Research Fund.
    • A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
    • See All 70 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020 07; 583(7816):459-468.

View in: PubMed

subject areas
  • Animals
  • Antiviral Agents
  • Betacoronavirus
  • Cloning, Molecular
  • Coronavirus Infections
  • Drug Evaluation, Preclinical
  • Drug Repositioning
  • HEK293 Cells
  • Host-Pathogen Interactions
  • Humans
  • Immunity, Innate
  • Mass Spectrometry
  • Molecular Targeted Therapy
  • Pandemics
  • Pneumonia, Viral
  • Protein Binding
  • Protein Biosynthesis
  • Protein Domains
  • Protein Interaction Mapping
  • Protein Interaction Maps
  • Receptors, sigma
  • SKP Cullin F-Box Protein Ligases
  • Vero Cells
  • Viral Proteins

authors with profiles
  • John D. Gross